Shareholders Equity: The sum of preferred and common equity items.
Silo Pharma, Inc. (SILO) had Shareholders Equity of $5.03M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.07M |
|
$-4.39M |
|
$0.01M |
|
$0.07M |
|
$4.78M |
|
$-4.71M |
|
$0.31M |
|
$-4.39M |
|
$-4.39M |
|
$-4.39M |
|
$-4.39M |
|
$-4.39M |
|
$-4.39M |
|
$-4.71M |
|
$-4.70M |
|
3.68M |
|
3.68M |
|
$-1.19 |
|
$-1.19 |
|
| Balance Sheet Financials | |
$7.11M |
|
-- |
|
$0.30M |
|
$7.41M |
|
$1.66M |
|
-- |
|
$0.72M |
|
$2.38M |
|
$5.03M |
|
$4.79M |
|
|
Shareholders Equity |
$5.03M |
4.48M |
|
| Cash Flow Statement Financials | |
$-3.83M |
|
$0.97M |
|
$3.24M |
|
$3.52M |
|
$3.91M |
|
$0.38M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.29 |
|
-- |
|
-- |
|
-- |
|
-- |
|
91.90% |
|
-6526.44% |
|
-6526.44% |
|
-6517.86% |
|
-6092.59% |
|
-6092.59% |
|
$-3.83M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-87.26% |
|
-91.65% |
|
-59.27% |
|
-87.26% |
|
$1.12 |
|
$-1.04 |
|
$-1.04 |
|